Advanced search
Publication Cover
Patient Preference and Adherence Volume 11, 2017 - Issue
Submit an article Journal homepage
66
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Patient-reported outcome assessment of inflammatory arthritis patient experience with intravenously administered biologic therapy

Norman B Gaylis1 Arthritis & Rheumatic Disease Specialties, Aventura, FL, USACorrespondence[email protected]
,
Joanne Sagliani1 Arthritis & Rheumatic Disease Specialties, Aventura, FL, USA
,
Shawn Black2 Medical Affairs Rheumatology, Janssen Scientific Affairs, LLC, Horsham, PA, USA
,
Kezhen L Tang3 Quantitative Sciences, Janssen Research & Development, LLC, Spring House, PA, USA
,
Raphael DeHoratius2 Medical Affairs Rheumatology, Janssen Scientific Affairs, LLC, Horsham, PA, USA;4 Department of Medicine and Pharmacology, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA, USA
,
Wesley A Kafka2 Medical Affairs Rheumatology, Janssen Scientific Affairs, LLC, Horsham, PA, USA
&
Dennis Parenti2 Medical Affairs Rheumatology, Janssen Scientific Affairs, LLC, Horsham, PA, USA
 show all
Pages 1543-1553 | Published online: 12 Sep 2017

References

  • CharlesCGafniAWhelanTDecision-making in the physician-patient encounter: revisiting the shared treatment decision-making modelSoc Sci Med199949565166110452420
  • SylwestrzakGLiuJStephensonJJRuggieriAPDeVriesAConsidering patient preferences when selecting anti-tumor necrosis factor therapeutic optionsAm Health Drug Benefits201472718124991392
  • ScarpatoSAntivalleMFavalliEGPatient preferences in the choice of anti-TNF therapies in rheumatoid arthritis. Results from a questionnaire survey (RIVIERA study)Rheumatology (Oxford)201049228929419920093
  • NotaIDrossaertCHTaalEVonkemanHEvan de LaarMAPatient participation in decisions about disease modifying anti-rheumatic drugs: a cross-sectional surveyBMC Musculoskelet Disord20141533325281209
  • SaltEPedenAThe complexity of the treatment: the decision-making process among women with rheumatoid arthritisQual Health Res201121221422220798264
  • CurtisJRShanYHarroldLZhangJGreenbergJDReedGWPatient perspectives on achieving treat-to-target goals: a critical examination of patient-reported outcomesArthritis Care Res (Hoboken)201365101707171223740824
  • MartinRWHeadAJReneJPatient decision-making related to antirheumatic drugs in rheumatoid arthritis: the importance of patient trust of physicianJ Rheumatol200835461862418278840
  • BolgeSCEldridgeHMLoflandJHRavinCHartPJInghamMPPatient experience with intravenous biologic therapies for ankylosing spondylitis, Crohn’s disease, psoriatic arthritis, psoriasis, rheumatoid arthritis, and ulcerative colitisPatient Prefer Adher201711661669
  • De MitsSLenaertsJVander CruyssenBA nationwide survey on patient’s versus physician’s evaluation of biological therapy in rheumatoid arthritis in relation to disease activity and route of administration: The Be-Raise studyPLoS One20161111e016660727893771
  • HartRIMcDonaghJEThompsonBBeing as normal as possible: how young people ages 16–25 years evaluate the risks and benefits of treatment for inflammatory arthritisArthritis Care Res (Hoboken)20166891288129427040737
  • HelmickCGFelsonDTLawrenceRCEstimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part IArthritis Rheum2008581152518163481

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.